ENTITY

Checkpoint Therapeutics (CKPT US)

11
Analysis
Health Care • United States
Checkpoint Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on the acquisition, development, and commercialization of immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics serves patients in the United States.
more
•18 Mar 2025 09:00•Issuer-paid

Biopharma Week in Review - March 17, 2025

Trump’s pick for CDC director, former Congressman Dave Weldon, had his nomination withdrawn just hours before the Senate committee hearing.

Logo
251 Views
Share
•16 Mar 2025 08:30

APAC Healthcare Weekly (Mar 16)- Celltrion, Ono Pharma, Sun Pharma, Syngene, Zydus, Sichuan Kelun

APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...

Logo
549 Views
Share
•13 Mar 2025 11:30

How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma?

​Sun Pharma to acquire Checkpoint Therapeutics for $355 million, boosting onco-dermatology portfolio with FDA-approved UNLOXCYT™, gaining access to...

Logo
488 Views
Share
•12 Mar 2025 07:31•Broker

Sun Pharmaceutical Industries: Checkpoint Acquisition to Strengthen Specialty Business.

Sun Pharma (SUNP) and Checkpoint Therapeutics Inc (Checkpoint) have entered into an agreement under which SUNP will acquire Checkpoint, an...

Logo
305 Views
Share
•10 Mar 2025 17:47

Sun Pharmaceutical (SUNP IN): Checkpoint Acquisition Does Not Check All the Boxes

​Sun Pharm plans to acquire Checkpoint Therapeutics for ~$200M. Sun's offer for Checkpoint seems compelling. However, the acquisition will not be...

Logo
533 Views
Share
x